News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,325 Results
Type
Article (47636)
Company Profile (121)
Press Release (546557)
Multimedia
Podcasts (160)
Webinars (22)
Section
Business (156212)
Career Advice (2435)
Deals (29247)
Drug Delivery (160)
Drug Development (71876)
Employer Resources (160)
FDA (16237)
Job Trends (12589)
News (280907)
Policy (30817)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2407)
Academic (1)
Accelerated approval (48)
Adcomms (37)
Allergies (158)
Alliances (37142)
ALS (195)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (431)
Approvals (16451)
Artificial intelligence (595)
Autoimmune disease (247)
Automation (42)
Bankruptcy (320)
Best Places to Work (9660)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (73)
Bladder cancer (184)
Brain cancer (64)
Breast cancer (665)
Cancer (5382)
Cardiovascular disease (469)
Career advice (2066)
Career pathing (45)
CAR-T (284)
CDC (73)
Celiac Disease (1)
Cell therapy (809)
Cervical cancer (44)
Clinical research (62394)
Collaboration (1760)
Company closure (6)
Compensation (1323)
Complete response letters (99)
COVID-19 (2782)
CRISPR (98)
C-suite (980)
Cystic fibrosis (150)
Data (7106)
Decentralized trials (3)
Denatured (36)
Depression (175)
Dermatology (67)
Diabetes (550)
Diagnostics (5938)
Digital health (44)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (271)
Drug pricing (234)
Drug shortages (34)
Duchenne muscular dystrophy (282)
Earnings (71036)
Editorial (75)
Employer branding (20)
Employer resources (142)
Events (98125)
Executive appointments (979)
FDA (19766)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1466)
Gene editing (215)
Generative AI (55)
Gene therapy (698)
GLP-1 (1153)
Government (4501)
Grass and pollen (8)
Guidances (393)
Healthcare (15750)
HIV (79)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (324)
Immuno-oncology (91)
Indications (154)
Infectious disease (3103)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (124)
Intellectual property (263)
Interviews (456)
IPO (14716)
IRA (58)
Job creations (3218)
Job search strategy (1681)
JPM (69)
Kidney cancer (20)
Labor market (96)
Layoffs (630)
Leadership (47)
Legal (7237)
Liver cancer (98)
Longevity (25)
Lung cancer (719)
Lymphoma (401)
Machine learning (53)
Management (52)
Manufacturing (905)
MASH (187)
Medical device (12066)
Medtech (12138)
Mergers & acquisitions (15646)
Metabolic disorders (1520)
mRNA (212)
Multiple sclerosis (169)
NASH (23)
Neurodegenerative disease (406)
Neuropsychiatric disorders (114)
Neuroscience (3270)
Neurotech (2)
NextGen: Class of 2026 (5218)
Non-profit (3411)
Now hiring (36)
Obesity (756)
Opinion (308)
Ovarian cancer (191)
Pain (228)
Pancreatic cancer (275)
Parkinson's disease (349)
Partnered (26)
Patents (543)
Patient recruitment (599)
Peanut (59)
People (46210)
Pharmaceutical (35)
Pharmacy benefit managers (34)
Phase 1 (18576)
Phase 2 (27124)
Phase 3 (21995)
Pipeline (7338)
Policy (370)
Postmarket research (2381)
Preclinical (7717)
Press Release (37)
Prostate cancer (290)
Psychedelics (63)
Radiopharmaceuticals (292)
Rare diseases (1076)
Real estate (4454)
Recruiting (65)
Regulatory (24313)
Reports (47)
Research institute (2181)
Resumes & cover letters (406)
Rett syndrome (34)
RNA editing (19)
RSV (84)
Schizophrenia (176)
Series A (247)
Series B (191)
Service/supplier (9)
Sickle cell disease (108)
Special edition (28)
Spinal muscular atrophy (152)
Sponsored (51)
Startups (2881)
State (1)
Stomach cancer (21)
Supply chain (125)
Tariffs (104)
The Weekly (122)
Vaccines (1167)
Venture capital (110)
Weight loss (535)
Women's health (100)
Worklife (24)
Date
Last 7 days (712)
Last 30 days (2490)
Last 365 days (29097)
2026 (9414)
2025 (29092)
2024 (32362)
2023 (36360)
2022 (46519)
2021 (50203)
2020 (47190)
2019 (38128)
2018 (28867)
2017 (28813)
2016 (27344)
2015 (30614)
2014 (24113)
2013 (19576)
2012 (21041)
2011 (21511)
2010 (19458)
Location
Africa (700)
Alabama (80)
Alaska (6)
Arizona (275)
Arkansas (12)
Asia (33980)
Australia (5949)
California (11980)
Canada (2924)
China (1103)
Colorado (483)
Connecticut (528)
Delaware (349)
Europe (82951)
Florida (1793)
Georgia (372)
Hawaii (4)
Idaho (43)
Illinois (898)
India (72)
Indiana (504)
Iowa (23)
Japan (491)
Kansas (109)
Kentucky (35)
Louisiana (30)
Maine (77)
Maryland (1449)
Massachusetts (8594)
Michigan (300)
Minnesota (631)
Mississippi (5)
Missouri (137)
Montana (13)
Nebraska (23)
Nevada (126)
New Hampshire (66)
New Jersey (3226)
New Mexico (16)
New York (3126)
North Carolina (1531)
North Dakota (7)
Northern California (6033)
Ohio (323)
Oklahoma (17)
Oregon (34)
Pennsylvania (2300)
Puerto Rico (22)
Rhode Island (34)
South America (1059)
South Carolina (82)
South Dakota (2)
Southern California (4715)
Tennessee (177)
Texas (1826)
United States (41863)
Utah (321)
Virginia (286)
Washington D.C. (75)
Washington State (956)
West Virginia (4)
Wisconsin (122)
Wyoming (1)
594,325 Results for "dompe famaceutici s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
March 20, 2026
·
2 min read
Press Releases
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
April 23, 2026
·
3 min read
Press Releases
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 29, 2026
·
2 min read
Press Releases
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
April 14, 2026
·
1 min read
Deals
Obesity’s explosive growth continues as Q1 deals exceed total 2025 value
Commitments in obesity- and diabetes-focused deals reached $22 billion in the first quarter of 2026—already eclipsing last year’s total of $20.3 billion, according to a new J.P. Morgan report.
April 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
March 16, 2026
·
12 min read
Press Releases
Indivior Announces Inclusion in the S&P SmallCap 600® Index
December 23, 2025
·
1 min read
Press Releases
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 8, 2026
·
3 min read
Press Releases
/U P D A T E -- Nuvation Bio Inc./
April 22, 2026
·
14 min read
Press Releases
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 5, 2026
·
1 min read
1 of 59,433
Next
